← Back to Journal
Post-Inflammatory Hyperpigmentation (PIH): Causes, Prevention, and Treatment
Skincare9 min read

Post-Inflammatory Hyperpigmentation (PIH): Causes, Prevention, and Treatment

Post-inflammatory hyperpigmentation affects darker skin tones disproportionately and is often undertreated. This comprehensive guide covers what PIH is, the top 5 proven ingredients ranked by efficacy, and the indispensable role of SPF.

K

Kwame Osei

Dermatology Contributor Β· Published 1 July 2026

What PIH is vs melasma vs sunspots: the critical distinction

Post-inflammatory hyperpigmentation is often confused with melasma and sunspots β€” all three are forms of excess pigmentation, but they have different causes and require different treatment approaches. Post-inflammatory hyperpigmentation (PIH): appears as dark marks or patches following any skin injury or inflammation β€” acne breakouts, eczema flares, cuts, scratches, aggressive exfoliation, or even overly aggressive medical procedures (microneedling, chemical peels). The mechanism: inflammation triggers melanocytes to produce excess melanin, which deposits in the epidermis (surface layer of skin). PIH is usually epidermal (surface-level), relatively recent in onset (weeks to months after the triggering injury), and more responsive to topical treatment than dermal PIH. Melasma: appears as larger patches of discolouration, typically on the face, triggered by hormonal changes (pregnancy, oral contraceptives), chronic sun exposure, and genetic predisposition. Often involves both epidermal and dermal melanin deposition, making it harder to treat than PIH. Sunspots (solar lentigines): discrete, well-demarcated spots caused by cumulative UV damage over years. Usually appear after age 30 on sun-exposed areas (face, hands, shoulders). Stable and slow-changing compared to PIH. The treatment protocols for each are different β€” treating PIH requires different ingredients than treating melasma or sunspots. For PIH specifically, addressing the inflammation is as important as addressing the melanin.

Why melanin-rich skin is more prone to PIH: the biology

Melanin-rich skin types (Fitzpatrick IV–VI) are disproportionately affected by PIH compared to lighter skin types. The biological reason: melanin-rich skin has higher melanocyte activity and more reactive melanocytes. When inflammation occurs (from any cause), the melanocytes in melanin-rich skin produce significantly more melanin than the same inflammatory stimulus would produce in lighter skin. Additionally, melanin is stored in melanosomes β€” organelles within melanocytes. In darker skin, there are more melanosomes and they are larger and more densely packed. When inflammation triggers melanin production, the sheer quantity of melanin produced exceeds what might accumulate in lighter skin. Furthermore, melanin-rich skin has a slightly altered distribution of melanocytes throughout the epidermis β€” melanocytes are slightly more numerous and distributed more deeply into dermal layers, making melanic marks potentially harder to treat topically. The result: acne breakout in melanin-rich skin often leaves a dark mark that persists for months or years, whereas the same acne in lighter skin might leave only a temporary red mark that fades in weeks. Understanding this biological reality is crucial for setting appropriate treatment expectations and choosing the right ingredients.

The top 5 proven ingredients ranked by evidence and tolerability

Ranked by efficacy (clinical trial evidence) and tolerability for melanin-rich skin: (1) Azelaic acid 10–20%: produced naturally by skin's own microbiota (Malassezia yeast). Simultaneously anti-inflammatory (reduces TNF-alpha and IL-8 cytokines that drive melanin production) and a tyrosinase inhibitor (directly blocks melanin synthesis). Additionally, azelaic acid has antimicrobial activity, making it particularly effective for PIH that co-exists with acne. A 2015 meta-analysis found 20% azelaic acid equivalent in efficacy to 4% hydroquinone for treating melasma and PIH, with superior tolerability. Best for melanin-rich skin: the anti-inflammatory action prevents reactive hyperpigmentation while the tyrosinase inhibition addresses existing marks. (2) Kojic acid 1–2%: well-studied tyrosinase inhibitor. A 2019 study found kojic acid 1% reduced hyperpigmented macules significantly over 12 weeks. Drawback: some people experience contact sensitivity; always patch test first. (3) Niacinamide 5–10%: reduces melanin transfer to keratinocytes and provides barrier support. Less potent than azelaic acid or kojic acid for pure brightening, but gentler and less irritating. Excellent for sensitive skin or as a foundation ingredient in a routine addressing PIH. (4) Tranexamic acid 2–5%: blocks plasminogen activator, reducing melanocyte stimulation. Gentler than kojic acid; particularly effective for melasma and hormone-triggered hyperpigmentation. (5) Retinol 0.025–0.1%: accelerates cell turnover, bringing new, less-pigmented skin cells to the surface. Also inhibits tyrosinase. Requires careful introduction in melanin-rich skin (use buffering technique) but powerfully addresses PIH over time.

What makes PIH worse: avoiding these triggers

Certain behaviors and products dramatically worsen PIH and should be strictly avoided while treating hyperpigmentation. Picking or friction: touching, picking, or scratching hyperpigmented areas triggers new inflammation and melanin production, darkening the mark further. Hands off β€” literally. Friction from rough towels, aggressive rubbing, or tight clothing on the affected area also triggers irritation and worsening. Heat exposure: heat increases blood flow and inflammation. Avoid very hot showers or baths, saunas, heated yoga, or prolonged sun exposure during PIH treatment. Heat-induced inflammation produces new melanin and darkens existing marks. Wrong actives: using high-concentration AHA, BHA, vitamin C, or retinol without proper buffering triggers irritation, inflammation, and reactive hyperpigmentation in melanin-rich skin. Overheating: as above, thermally-induced inflammation is the enemy of PIH treatment. Keep skin cool. UV exposure: this is discussed separately (see SPF section), but critical to mention here. Any unprotected UV exposure instantly worsens PIH. Over-exfoliation: excessive physical or chemical exfoliation disrupts the barrier and triggers inflammation, producing the exact melanin surge you are trying to prevent. Limit exfoliation to once weekly maximum while treating PIH.

The indispensable role of SPF: non-negotiable daily protection

SPF is not optional when treating any form of hyperpigmentation β€” it is the foundation that all treatment rests upon. Here is why: UV radiation directly stimulates melanin production through multiple pathways. UVB causes direct DNA damage, triggering an inflammatory response that drives melanin synthesis. UVA penetrates deeper and can activate melanin-producing signalling cascades. When you use brightening actives to inhibit melanin synthesis, and then expose that skin to unprotected sun, the UV radiation immediately reverses the treatment by ramping up melanin production again. Additionally, UV exposure worsens the existing hyperpigmented marks by stimulating additional melanin deposition in already-dark areas. The result: using a kojic acid serum diligently for weeks, then going unprotected in the sun, can undo all progress. For melanin-rich skin treating PIH: minimum SPF 30 daily. SPF 50 is strongly preferred if you have active hyperpigmentation marks being treated. Apply 1.5ml (about one-quarter teaspoon) to face and neck. Reapply every 2 hours if outdoors. The formula must be broad-spectrum (protecting against both UVA and UVB). For deeper skin tones, seek out tinted mineral formulations or hybrid formulas to avoid white cast β€” white cast sunscreens are less likely to be used consistently, which completely negates their protection.

Realistic treatment timeline and when to see a dermatologist

Post-inflammatory hyperpigmentation responds to treatment, but the timeline depends on the severity and depth of the mark. Epidermal PIH (surface-level, most common): 3–6 months of consistent treatment with azelaic acid, kojic acid, or niacinamide + daily SPF to see obvious improvement. Some marks fade completely within this timeline; others remain visible but much lighter. Dermal PIH (pigment deposits deeper in the skin): 6–12 months minimum, as dermal pigment is harder for topical products to reach. Some dermal PIH may never fully resolve with topical treatment alone. Mixed epidermal-dermal PIH: 6–9 months of consistent treatment. Important timeline factors: consistency is everything. Sporadic treatment produces almost no results. Daily SPF compliance is mandatory β€” even one day of unprotected sun exposure can reset progress. When to see a dermatologist: (1) PIH that has not improved after 6 months of consistent treatment with proven ingredients and SPF use. (2) Very dark, thick, or raised marks that may be keloids or hypertrophic scars (these are structural problems requiring professional treatment). (3) PIH affecting large areas of the face or body. (4) Any mark that is itching, changing colour, or becoming larger β€” these could indicate a condition requiring professional evaluation. Professional options: dermatologists can prescribe higher-concentration hydroquinone (4%+), tretinoin, or other prescription retinoids. They can also recommend procedures like chemical peels, microneedling, or laser treatments (though laser treatments on melanin-rich skin require careful selection to avoid worsening PIH). The goal is to use topical treatment first and reserve professional intervention for cases that do not respond.

#PIH#post-inflammatory hyperpigmentation#dark marks#acne marks#treatment#prevention